Indaco Venture Partners

Indaco Venture Partners SGR is an Italian venture capital asset management company based in Milan, specializing in growth-stage investments in innovative sectors such as electronics, robotics, medtech, and new materials. Founded in 2016, the firm primarily focuses on Italian enterprises but also invests across Europe, the USA, Canada, and Israel. Indaco Venture Partners seeks to support companies that have a competitive edge through proprietary technologies and innovations, targeting those in sectors that demonstrate significant potential for advancement and disruption.

Alvise Bonivento Ph.D

Co-Founder, Investment Director & Board Member

Cosimo Calcagno

Investment Manager

Davide Turco

Co-Founder & Managing Director

25 past transactions

InnovHeart

Series C in 2022
InnovHeart s.r.l. manufactures transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease. The company offers Saturn TMVR system a mitral heart valve designed for trans-apical or trans-septal delivery systems. InnovHeart s.r.l. was founded in 2015 and is based in Milan, Italy with an additional office in Newton, Massachusetts.

CYSEC

Seed Round in 2022
CYSEC is a startup working on next generation Confidential Computing solutions securing data at rest, in motion and in use. Currently they have released their ARCA solution which is quickly becoming one of the more popular choices in the market.

CellPly

Venture Round in 2021
CellPly s.r.l. develops innovative diagnostic tools aimed at personalizing cancer treatment for clinicians and researchers. Founded in 2013 and based in Bologna, Italy, the company provides a platform that analyzes small ex-vivo samples and rare cells immediately after acquisition from patients, while preserving the microenvironment conditions. This approach yields critical insights into tumor cell sensitivity to various drugs and the in-vivo status of immune cells in proximity to tumors. By utilizing CellPly's solutions, oncologists can select optimal treatment options, scientists can study cellular responses to therapies, and pharmaceutical companies can enhance drug efficacy and improve outcomes for drugs with limited effectiveness through better patient stratification.

Cortilia

Series C in 2021
Cortilia S.p.A. is a prominent online food retailer based in Milan, Italy, specializing in the sale of fresh food products. Established in 2011, the company provides a diverse range of items, including fruits, vegetables, fish, meat, dairy products, ready meals, pasta, bread, rice, desserts, snacks, and beverages. Cortilia is recognized for its commitment to delivering high-quality products sourced from local and reputable producers, ensuring a superior customer experience. In addition to its core offerings, the company also provides food storage services to enhance convenience for its clients. With a presence in Milan, Turin, and Bologna, Cortilia has established itself as a leader in the Italian online fresh food market.

WISE

Series C in 2020
WISE Srl, established in 2011 and headquartered in Milan, Italy, specializes in the manufacture of implantable biomedical devices for biotechnology and biomedicine applications. The company employs advanced supersonic cluster beam implantation technology to integrate biocompatible, flexible, and stretchable conductive micro-electrodes into polymers, particularly elastomers. This innovative approach is primarily utilized in developing leads for neurostimulation, which are implanted in the spinal cord or brain to address neurodegenerative conditions such as chronic pain and Parkinson's disease. WISE aims to create a new generation of neuromodulation leads that are unbreakable, less invasive, and more cost-effective, enhancing treatment options for patients.

InnovHeart

Series B in 2020
InnovHeart s.r.l. manufactures transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease. The company offers Saturn TMVR system a mitral heart valve designed for trans-apical or trans-septal delivery systems. InnovHeart s.r.l. was founded in 2015 and is based in Milan, Italy with an additional office in Newton, Massachusetts.

Enthera

Series A in 2020
Enthera S.r.l. is a biotechnology company based in Milan, Italy, founded in 2016. The company focuses on developing innovative therapeutic approaches for diabetes and related gastrointestinal complications, particularly enteropathy, along with other intestinal disorders that share similar biological pathways. Enthera operates a monoclonal antibody discovery platform to create first-in-class biologics aimed at addressing these underserved conditions. The company was established as a subsidiary of BiovelocITA S.r.l. and was founded in collaboration with scientists Prof. Paolo Fiorina and Dr. Francesca D’Addio. The name "Enthera" is derived from a combination of the terms "entero," referring to the intestine, and "therapy," reflecting its commitment to developing targeted treatments.

Expert.ai

Post in 2020
Expert System provides technology and tools that support the creation, development, implementation and management of AI applications to unlock the value of language in the enterprise at speed and scale. Its flagship platform provides a mix of natural language understanding and machine learning algorithms to help organizations bring humanlike comprehension of any kind of text to accelerate business processes, enhance knowledge discovery and improve decision making. Headquartered in Italy, the company operates throughout Europe, the Americas, Canada and the Middle East across a vast range of sectors and use cases including content enrichment, customer care, compliance, third party risk mitigation and intelligence applications.

D-Orbit

Series C in 2019
D-Orbit S.r.l. is an Italian company that specializes in satellite solutions, focusing on the design, development, launch, commissioning, and decommissioning of satellites. Founded in 2011 and headquartered in Sesto Fiorentino, Italy, D-Orbit aims to provide innovative technologies for the safe disposal of artificial satellites at the end of their operational life, thereby reducing space debris. The company serves satellite owners and operators, offering products and services that enhance the efficiency and reliability of satellite missions while minimizing costs. D-Orbit also emphasizes the social and environmental benefits of its solutions, striving to streamline all phases of satellite operations. With approximately 35 employees, D-Orbit has expanded its reach with subsidiaries in Washington, DC, and Lisbon, Portugal.

D-Orbit

Series B in 2019
D-Orbit S.r.l. is an Italian company that specializes in satellite solutions, focusing on the design, development, launch, commissioning, and decommissioning of satellites. Founded in 2011 and headquartered in Sesto Fiorentino, Italy, D-Orbit aims to provide innovative technologies for the safe disposal of artificial satellites at the end of their operational life, thereby reducing space debris. The company serves satellite owners and operators, offering products and services that enhance the efficiency and reliability of satellite missions while minimizing costs. D-Orbit also emphasizes the social and environmental benefits of its solutions, striving to streamline all phases of satellite operations. With approximately 35 employees, D-Orbit has expanded its reach with subsidiaries in Washington, DC, and Lisbon, Portugal.

Intrepida Bio

Venture Round in 2019
Intrepida Bio, Inc., a biotechnology company, develops cancer drugs that alter the body’s first line of defense, and innate immunity. It also discovers and develops medicines that modulate the innate immune system to fight cancer and other diseases; and develops monoclonal antibodies that block the novel targets BAG3 and its receptor IFITM-2 to thwart their ability to create a favorable environment for tumor growth. Intrepida Bio, Inc. was incorporated in 2016 and is headquartered in San Diego, California.

Newronika

Series A in 2019
Newronika s.r.l. is a Milan-based company that specializes in the manufacture and marketing of neuromodulation systems aimed at addressing brain-related issues. Established in 2016 as a spin-off from prominent research institutions, including Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika combines expertise from various fields such as neuroscience, neurophysiology, and biomedical engineering. The company offers innovative therapeutic tools like WebBioBank, a web-based platform utilizing transcranial direct current stimulation (tDCS) for long-term functional changes in the cerebral cortex, and the HDCkit system, which includes a programmable stimulator designed to enhance treatment efficacy while ensuring patient safety. Newronika's products are distributed in the United Kingdom and internationally, targeting chronic pain, cravings, depression, and stroke rehabilitation, ultimately aiming to improve patients' quality of life through precise stimulation techniques.

Cortilia

Series B in 2019
Cortilia S.p.A. is a prominent online food retailer based in Milan, Italy, specializing in the sale of fresh food products. Established in 2011, the company provides a diverse range of items, including fruits, vegetables, fish, meat, dairy products, ready meals, pasta, bread, rice, desserts, snacks, and beverages. Cortilia is recognized for its commitment to delivering high-quality products sourced from local and reputable producers, ensuring a superior customer experience. In addition to its core offerings, the company also provides food storage services to enhance convenience for its clients. With a presence in Milan, Turin, and Bologna, Cortilia has established itself as a leader in the Italian online fresh food market.

BiovelocITA

Venture Round in 2019
BiovelocITA brings together best-in-class scientists, entrepreneurs and investors to foster the development of pioneering companies. BiovelocITA is co-founded and promoted by Sofinnova Partners, a historical player on the Italian biotech market. Active in Italy for more than fifteen years, Sofinnova Partners is in a privileged position to help Italy grow into one of Europe’s strongest biotech market.

UltraSoC

Series E in 2019
UltraSoC Technologies Ltd. specializes in semiconductor intellectual property (IP) focused on system monitoring, analysis, and optimization for advanced systems-on-chip (SoC) devices. Founded in 2005 and headquartered in Cambridge, UK, the company offers a comprehensive toolkit that includes dedicated and optimized IP, as well as configurable modules for design-time and run-time adjustment. Its technology facilitates non-intrusive, wire-speed monitoring of SoC behavior, allowing engineers to understand complex interactions among on-chip subsystems, buses, and software. This capability accelerates development and minimizes risks associated with SoC design. UltraSoC's solutions are applied in various contexts, including SoC debugging, analytics, optimization, and security applications, thereby enhancing the efficiency of embedded systems development. The company operates as a subsidiary of Siemens Aktiengesellschaft.

MainStreaming

Series B in 2019
MainStreaming is a video delivery network that offers a comprehensive cloud platform designed for video hosting and streaming. Founded in 2015 and headquartered in Milan, Italy, with additional offices in San Francisco, New York, and London, MainStreaming enables broadcasters, media, and gaming companies to deliver high-quality live and on-demand video to audiences globally. Its platform includes features for ingesting, encoding, managing, and distributing video content, along with a customizable professional video player that can be integrated into any website. MainStreaming also provides media delivery solutions, such as real-time content delivery networks, and professional consulting services to assist clients in online video distribution. The company serves a diverse range of industries, including broadcasting, OTT TV, online media, retail, education, and corporate sectors.

Sweetguest

Series B in 2019
Sweetguest s.r.l., founded in 2016 and based in Milan, Italy, specializes in providing comprehensive management services for short-term rental properties. The company has developed a mobile application that streamlines the reservation process and offers a full range of services to both property owners and their guests. Sweetguest manages all aspects of short-term rentals, including reservations, check-ins, check-outs, laundry, and cleaning. By handling these tasks, Sweetguest enables property owners to maximize their earnings while saving time and effort, ensuring a high-quality experience for everyone involved.

Talent garden

Series B in 2019
Talent Garden is a prominent innovation platform and coworking network that supports digital and technology professionals. Established in 2011 in Brescia, Italy, the company operates 23 campuses across eight countries, including Albania, Austria, Denmark, Ireland, Italy, Lithuania, Romania, and Spain. Talent Garden serves as a collaborative environment for startups, freelancers, and large corporations, fostering connections and professional development within the digital and tech sectors. The organization aims to cultivate vibrant, locally connected campuses that empower communities and enhance the growth of innovative ideas. With a growing membership of over 600 talents and more than 40,000 online community members, Talent Garden is dedicated to creating an ecosystem that nurtures entrepreneurial success and collaboration among professionals in the technology space.

Travel Appeal

Series A in 2018
Travel Appeal is a technology company based in Florence, Italy, that specializes in providing data-driven insights for the travel industry. Established in 2014, the company utilizes artificial intelligence to monitor and analyze vast amounts of geographical data, online feedback, and customer purchasing behaviors in real time. Its platform processes this information through proprietary algorithms and a semantic engine, delivering actionable insights to help businesses enhance their online reputation, optimize pricing strategies, and improve overall performance. Travel Appeal offers its services through various delivery methods, including API, mobile applications, and dashboards, catering to different levels of travel professionals. Its solutions are designed to assist hotels, restaurants, museums, and destinations in maximizing customer experiences and staying competitive in the market.

Bendit

Convertible Note in 2018
Bendit Technologies Ltd. is a medical company specializing in the development and manufacturing of innovative catheters that utilize a unique bending technology to enhance steering capabilities in both micro and conventional catheter wires. Founded in 2013 and headquartered in Petach Tikva, Israel, the company focuses on creating small and flexible microcatheters designed for optimal navigation through vessels with complex anatomies. Bendit's products aim to improve the precision of medical procedures by enabling doctors to direct the catheters effectively, thereby minimizing risks and enhancing success rates. The company's expertise is bolstered by a joint venture of experienced professionals from production, quality, regulation, and development sectors within the medical field.

Easy Rain

Series A in 2017
Easy Rain’s mission is to improve the safety of wheel vehicles, by contrasting a problem has not currently been addressed by any safety device, being the hydroplaning phenomenon. Hydroplaning is a phenomenon that causes loss of traction between a vehicle’s wheels and the roads surface due to the presence of a layer of water. Millions of accidents every year on wet roads. Also Autonomous driving technology has a big issue with wet roads. Easy Rain developed, tested, validated and patented a new driver assistance system specifically designed to contrast hydroplaning. The system prevents large amounts of water from touching the tire, thereby improving a vehicle’s performance and safety, by increasing the adherence of the tire on wet surfaces.

Bendit

Series A in 2017
Bendit Technologies Ltd. is a medical company specializing in the development and manufacturing of innovative catheters that utilize a unique bending technology to enhance steering capabilities in both micro and conventional catheter wires. Founded in 2013 and headquartered in Petach Tikva, Israel, the company focuses on creating small and flexible microcatheters designed for optimal navigation through vessels with complex anatomies. Bendit's products aim to improve the precision of medical procedures by enabling doctors to direct the catheters effectively, thereby minimizing risks and enhancing success rates. The company's expertise is bolstered by a joint venture of experienced professionals from production, quality, regulation, and development sectors within the medical field.

UltraSoC

Series D in 2017
UltraSoC Technologies Ltd. specializes in semiconductor intellectual property (IP) focused on system monitoring, analysis, and optimization for advanced systems-on-chip (SoC) devices. Founded in 2005 and headquartered in Cambridge, UK, the company offers a comprehensive toolkit that includes dedicated and optimized IP, as well as configurable modules for design-time and run-time adjustment. Its technology facilitates non-intrusive, wire-speed monitoring of SoC behavior, allowing engineers to understand complex interactions among on-chip subsystems, buses, and software. This capability accelerates development and minimizes risks associated with SoC design. UltraSoC's solutions are applied in various contexts, including SoC debugging, analytics, optimization, and security applications, thereby enhancing the efficiency of embedded systems development. The company operates as a subsidiary of Siemens Aktiengesellschaft.

Directa Plus

Venture Round in 2015
Directa Plus is a technology company based in Lomazzo, Italy, specializing in the manufacture and supply of graphene-based products for industrial and commercial applications. Founded in 2005, it operates through three main segments: Textile, Environmental, and Others. The company produces a range of products marketed under the G+ brand, which are utilized in various fields, including elastomers, smart textiles, composite materials, wastewater treatment, and oil-spill recovery. Directa Plus has a significant focus on environmental applications, generating the majority of its revenue from this segment. Through its innovative approach to nanotechnology, the company aims to enhance product performance across diverse industries.

CellPly

Seed Round in 2014
CellPly s.r.l. develops innovative diagnostic tools aimed at personalizing cancer treatment for clinicians and researchers. Founded in 2013 and based in Bologna, Italy, the company provides a platform that analyzes small ex-vivo samples and rare cells immediately after acquisition from patients, while preserving the microenvironment conditions. This approach yields critical insights into tumor cell sensitivity to various drugs and the in-vivo status of immune cells in proximity to tumors. By utilizing CellPly's solutions, oncologists can select optimal treatment options, scientists can study cellular responses to therapies, and pharmaceutical companies can enhance drug efficacy and improve outcomes for drugs with limited effectiveness through better patient stratification.